ACP

Acuta Capital Partners Portfolio holdings

AUM $147M
1-Year Est. Return 491.59%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+491.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$371M
AUM Growth
+$126M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
77
New
Increased
Reduced
Closed

Top Buys

1
+$51.2M
2
+$15M
3
+$9.52M
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$4.24M
5
NVTA
Invitae Corporation
NVTA
+$4.06M

Top Sells

1
+$12.2M
2
+$7.78M
3
+$5.12M
4
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$4.57M
5
ANAB icon
AnaptysBio
ANAB
+$3.96M

Sector Composition

1 Healthcare 70.42%
2 Communication Services 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$94.2M 25.4%
6,737,706
+5,137,706
2
$34.9M 9.42%
83,333
-2,506
3
$28.9M 7.79%
3,295,111
+214,966
4
$26.6M 7.17%
3,431,809
+16,765
5
$24.4M 6.57%
1,216
+1,037
6
$18.7M 5.05%
2,000,000
+262,460
7
$18.1M 4.89%
500,000
-424,483
8
$13.4M 3.63%
62,670
-12,561
9
$11.2M 3.01%
+3,333,333
10
$10.7M 2.88%
1,721,299
+362,948
11
$8.76M 2.36%
250,000
-51,700
12
$8.15M 2.2%
19,200
+8,423
13
$8.01M 2.16%
450,000
+169,400
14
$7.67M 2.07%
1,331,983
+645,596
15
$6.4M 1.73%
170,000
-80,000
16
$5.22M 1.41%
996,300
+827,615
17
$4.95M 1.33%
528,000
+427,708
18
$4.89M 1.32%
216,255
+63,418
19
$4.69M 1.26%
5,093,276
+333,125
20
$4.52M 1.22%
+300,000
21
$4.33M 1.17%
827
+117
22
$3.28M 0.88%
1,600
-2,183
23
$3.13M 0.84%
+670
24
$2.81M 0.76%
14,229
+449
25
$2.77M 0.75%
+250,000
1
2 3 4